Endocrinology and metabolism (Seoul, Korea) · 2023
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ha Jeonghoon, Park Jung Hwan, Kim Kyoung Jin, Kim Jung Hee, Jung Kyong Yeun, Lee Jeongmin, Choi Jong Han, Lee Seung Hun, Hong Namki, Lim Jung Soo, Park Byung Kwan, Kim Jung-Han, Jung Kyeong Cheon, Cho Jooyoung, Kim Mi-Kyung, Chung Choon Hee, Committee of Clinical Practice Guideline of Korean Endocrine Society, Korean Adrenal Study Group of Korean Endocrine Society
Аннотация
Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary hypertension. It is characterized by an overproduction of aldosterone, leading to hypertension and/or hypokalemia. Despite affecting between 5.9% and 34% of patients with hypertension, PA is frequently missed due to a lack of clinical awareness and systematic screening, which can result in significant cardiovascular complications. To address this, medical societies have developed clinical practice guidelines to improve the management of hypertension and PA. The Korean Endocrine Society, drawing on a wealth of research, has formulated new guidelines for PA. A task force has been established to prepare PA guidelines, which encompass epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, and follow-up care. The Korean clinical guidelines for PA aim to deliver an evidence-based protocol for PA diagnosis, treatment, and patient monitoring. These guidelines are anticipated to ease the burden of this potentially curable condition.